Novartis presents first-of-its-kind algorithm-based tool to help MS patients and physicians Read more
Bicycle Therapeutics Enters Neuroscience Arena through Collaboration with Dementia Discovery Fund Read more
Verve Therapeutics Founded to Protect Against Heart Disease Launches with $58.5 Million in Series A Funding Led by GV Read more
EC Approves LORVIQUA (lorlatinib) for Certain Adult Patients with Previously-Treated ALK-Positive Advanced Non-Small Cell Lung Cancer Read more
Sensei Biotherapeutics Announces Clinical Trial Collaboration Agreement with AstraZeneca for Two Phase 2 Studies of SNS-301 Read more